Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BestTreat

Financiado

Cerrado

BestTreat Building a Gut Microbiome Engineering Toolbox for In Situ Therapeuti...

BestTreat Building a Gut Microbiome Engineering Toolbox for In Situ Therapeutic Treatments for Non alcoholic Fatty Liver Disease BestTreat fosters education of ESRs in a project to uncover microbiome signatures for risk prediction and monitoring of NAFLD and to contribute to the development of therapeutic treatments based on metabolically beneficial microbi... ver más

31/08/2022

Leibniz-HKI LEIBNI...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

LEIBNIZINSTITUT FUR NATURSTOFFFORSCHUNG UND I... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 15 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-08-31

MSCA-ITN-2018: Innovative Training Networks

I+D

Cerrada hace 7 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

15 Participantes

Leibniz-HKI LEIBNIZ INSTITUT...

758.37K€ | Lider

TECHNICAL UNIVERSITY OF DENM...

595.04K€ | Participante

CHR. HANSEN

297.52K€ | Participante

CLIM

297.52K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

FLORINASH The role of intestinal microflora in non alcoholic fatty liv... 7M€ Cerrado

MICFIB MICROBIOME-DRIVERS OF LIVER FIBROSIS 185K€ Cerrado

GALAXY GALAXY Gut and liver axis in alcoholic liver fibrosis 6M€ Cerrado

GutTransForm Gut microbiota drug biotransformation as a tool to unravel t... 2M€ Cerrado

BugDrug Modulating the gut microbiome to enhance drug efficacy 2M€ Cerrado

AGL2016-78311-R NUEVOS METODOS PARA EL CULTIVO Y CARACTERIZACION DE PROBIOTI... 278K€ Cerrado

Duración del proyecto: 48 meses Fecha Inicio: 2018-08-21
Fecha Fin: 2022-08-31

Líder del proyecto

LEIBNIZINSTITUT FUR NATURSTOFFFORSCHUNG UND I... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto BestTreat fosters education of ESRs in a project to uncover microbiome signatures for risk prediction and monitoring of NAFLD and to contribute to the development of therapeutic treatments based on metabolically beneficial microbial consortia. It trains 15 ESRs at world-leading academic institutions and companies, thus forming strong interdisciplinary links between industry, life and medical sciences, and end-users. BestTreat aims to train a new generation of highly qualified ESRs with entrepreneurial competencies in modern Life Sciences through state-of-the-art research projects. The projects focus on the identification and functional characterization of microbial consortia that contribute to metabolic control, and the application of this knowledge to develop novel leads for drug discovery and therapies for NAFLD. The new field on microbiome based therapeutics requires highly skilled scientists with interdisciplinary knowledge on medicine, systems biology and computer science, as well as hands-on experience with several types of tissue samples and model organisms that can optimally translate their research findings into sustainable improvements in clinical practice. BestTreat overcomes current barriers by establishing a strong, multidisciplinary and inter-sectoral training network, developing technologies tailored to solve key questions in human metabolism, microbiology and bioinformatics. The BestTreat programme will exploit recent developments in high-throughput and genome-wide screening technologies, combine these with modern molecular cell biology and systems biology approaches and ultimately translate the data into new leads for the discovery of live biotherapeutics. This specific cross-disciplinary training program will educate young scientists to the next level needed to advance this research field for the upcoming decennium. The training programme will be complemented with a complete set of transferable skills.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores